Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01989585
What this trial is testing

Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Malignant Solid Neoplasm+2 more
National Cancer Institute (NCI) 75
Large-scale testing (Phase 3)Study completedNCT00019682
What this trial is testing

Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma

Who this might be right for
Recurrent MelanomaStage IIIA Skin MelanomaStage IIIB Skin Melanoma+2 more
National Cancer Institute (NCI) 185
Testing effectiveness (Phase 2)WithdrawnNCT04987996
What this trial is testing

GR-MD-02 + Pembrolizumab Versus Pembrolizumab Monotherapy in Melanoma and Squamous Cell Head and Neck Cancer Patients

Who this might be right for
Metastatic MelanomaHead and Neck Squamous Cell Carcinoma
Providence Health & Services
Large-scale testing (Phase 3)Study completedNCT02166788
What this trial is testing

Evaluation of Groin Lymphadenectomy Extent For Metastatic Melanoma

Who this might be right for
Metastatic Melanoma to the Groin Lymph Nodes
Melanoma and Skin Cancer Trials Limited 634
Early research (Phase 1)Active Not RecruitingNCT01364051
What this trial is testing

Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies

Who this might be right for
Metastatic MelanomaRefractory Malignant Solid NeoplasmStage IV Cutaneous Melanoma AJCC v6 and v7+1 more
National Cancer Institute (NCI) 19
Early research (Phase 1)WithdrawnNCT02145910
What this trial is testing

Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases

Who this might be right for
Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)Ended earlyNCT00006003
What this trial is testing

SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Looking for participantsNCT04598009
What this trial is testing

Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
University of California, San Francisco 25
Very early researchStudy completedNCT00276835
What this trial is testing

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
Northwestern University 15
Testing effectiveness (Phase 2)Ended earlyNCT04152863
What this trial is testing

Efficacy, Safety, and Tolerability of Gebasaxturev (V937) Administered Intravenously or Intratumorally With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone in Participants With Advanced/Metastatic Melanoma (V937-011)

Who this might be right for
Advanced/Metastatic Melanoma
Merck Sharp & Dohme LLC 85
Testing effectiveness (Phase 2)Study completedNCT00204516
What this trial is testing

Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens

Who this might be right for
Malignant Melanoma
University Hospital Tuebingen 31
Testing effectiveness (Phase 2)Study completedNCT02583516
What this trial is testing

Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Grupo Español Multidisciplinar de Melanoma 70
Testing effectiveness (Phase 2)Ended earlyNCT04899921
What this trial is testing

Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets

Who this might be right for
MelanomaMetastatic Melanoma
Dana-Farber Cancer Institute 1
Early research (Phase 1)UnknownNCT06556004
What this trial is testing

Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients

Who this might be right for
Melanoma Stage IIIcMelanoma Stage IV
University of Chile 20
Testing effectiveness (Phase 2)Study completedNCT01258855
What this trial is testing

Aldesleukin With or Without Ziv-Aflibercept in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Metastatic MelanomaRecurrent MelanomaStage III Cutaneous Melanoma AJCC v7+4 more
National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Study completedNCT00281957
What this trial is testing

Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 109
Testing effectiveness (Phase 2)UnknownNCT01960829
What this trial is testing

Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study

Who this might be right for
MelanomaTOR Serine-Threonine KinasesNeoplasm Metastasis
Peking University Cancer Hospital & Institute 60
Very early researchEnded earlyNCT01730157
What this trial is testing

Radioembolization and Ipilimumab in Treating Patients With Uveal Melanoma With Liver Metastases

Who this might be right for
Ciliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeExtraocular Extension Melanoma+5 more
Case Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00125749
What this trial is testing

Vaccination of Patients With Stage IV Melanoma With Dendritic Cells

Who this might be right for
MelanomaNeoplasm Metastasis
Baylor Research Institute 30
Testing effectiveness (Phase 2)Study completedNCT00022438
What this trial is testing

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma That Has Not Responded to Previous Treatment

Who this might be right for
Melanoma (Skin)
National Cancer Institute (NCI)
Next Page